Melanoma May No Longer Be a Death Sentence

June 3 (Bloomberg) -- The next generation of experimental immune-boosting drugs from Merck, Bristol-Myers and Roche are producing such promising early results that doctors are openly speculating that some patients with the deadliest form of skin cancer may be cured. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
Mila Kunis Helps Miner Become Top Emerald Producer
50:06 - Gemfields CEO Ian Harebottle discusses the gemstone business with Bloomberg's Pimm Fox on "Taking Stock." (Source: Bloomberg)
  • Redfin CEO: How Apple Watch Will Change My Business
  • Is OrangeTheory the Next Big Thing in Fitness Data?
  • Behind the Documentary 'All Eyes and Ears'